Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
Clinical trial NCT04835168 · WITHDRAWN
Trial details
- NCT number
- NCT04835168
- Sponsor
- NImmune Biopharma
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-30
- Primary completion
- 2022-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.